未找到相关数据
Neoadjuvant and adjuvant nivolumab and lirilumab in patients with recurrent, resectable squamous cell carcinoma of the head and neck.
被引：19
作者：
Hanna, Glenn J.
O'Neill, Anne M.
Jo, Vickie Y.
Wong, Kristine
Lizotte, Patrick H.
Annino, Donald J.
Goguen, Laura A.
Kass, Jason I.
Rettig, Eleni M.
Sethi, Rosh K. V.
Lorch, Jochen H.
Schoenfeld, Jonathan D.
Margalit, Danielle N.
Tishler, Roy B.
Everett, Peter C.
Desai, Anupam M.
Paweletz, Cloud P.
Egloff, Ann Marie
Uppaluri, Ravindra
Haddad, Robert I.
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[3] Belfer Ctr Appl Canc Sci, Boston, MA USA
[4] Reliant Med Grp, Worcester, MA USA
[5] Boston Univ, Sch Med, Boston Med Ctr, Boston, MA 02118 USA
[6] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[7] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.6053
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6053
引用
收藏
页数：3
相关论文